Skip to main content
. 2020 Mar;12(3):916–924. doi: 10.21037/jtd.2019.12.56

Table 2. Pathological outcomes.

Pathological outcomes OE (n=77) VAMIE (n=144) RAMIE (n=91) P value
pT stage, n (%) 0.000
   T1 4 (5.19) 47 (32.64) 25 (27.47)
   T2 14 (18.18) 30 (20.83) 24 (26.37)
   T3 57 (74.03) 67 (46.53) 42 (46.15)
   T4 2 (2.60) 0 0
pN stage, n (%) 0.232
   N0 44 (57.14) 94 (65.28) 52 (57.14)
   N1 15 (19.48) 29 (20.14) 21 (23.08)
   N2 11 (14.29) 17 (11.81) 14 (15.38)
   N3 7 (9.09) 4 (2.78) 4 (4.40)
Tumor grade, n (%) 0.627
   G1 11 (14.29) 28 (19.44) 13 (14.29)
   G2 51 (66.23) 82 (56.94) 54 (59.34)
   G3 15 (19.48) 34 (23.61) 24 (26.37)
pTNM, n (%) 0.001
   I 5 (6.49) 40 (27.78) 18 (19.78)
   II 38 (49.35) 63 (43.75) 41 (45.05)
   III 26 (33.77) 37 (25.69) 28 (30.77)
   IVA 8 (10.39) 4 (2.78) 4 (4.40)

OE, open esophagectomy; VAMIE, video-assisted minimally invasive esophagectomy; RAMIE, robotic-assisted minimally invasive esophagectomy.